{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:45:09Z","timestamp":1792118709115,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.colsurfb.2022.112537","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T11:51:00Z","timestamp":1651837860000},"page":"112537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects"],"prefix":"10.1016","volume":"216","author":[{"given":"Maleeha","family":"Gul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najam-us","family":"Sahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhar ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqar","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Ik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Yeon","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Su","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alam","family":"Zeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2022.112537_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/0929867013373796","article-title":"Current trends in the development of new antidepressants","volume":"8","author":"Pacher","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.colsurfb.2022.112537_bib2","first-page":"437","article-title":"Antidepressants: mechanism of action, toxicity and possible amelioration","volume":"3","author":"Khushboo","year":"2017","journal-title":"J. Appl. Biotechnol. Bioeng."},{"key":"10.1016\/j.colsurfb.2022.112537_bib3","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.euroneuro.2014.06.013","article-title":"A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinities","volume":"24","author":"Michl","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.colsurfb.2022.112537_bib4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/JIR.S294413","article-title":"Natural dietary supplement, carvacrol, alleviates LPS-induced oxidative stress, neurodegeneration, and depressive-like behaviors via the Nrf2\/HO-1 pathway","volume":"14","author":"Naeem","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.colsurfb.2022.112537_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/11318640-000000000-00000","article-title":"Agomelatine: innovative pharmacological approach in depression","volume":"Suppl 2","author":"Popoli","year":"2009","journal-title":"CNS Drugs 23"},{"key":"10.1016\/j.colsurfb.2022.112537_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/00023210-200620120-00003","article-title":"Agomelatine: a preliminary review of a new antidepressant","volume":"20","author":"Zupancic","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.colsurfb.2022.112537_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/10837450.2021.1888980","article-title":"Brain targeting of agomelatine egg lecithin based chitosan coated nanoemulsion","volume":"26","author":"Shukr","year":"2021","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2022.112537_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11095-018-2538-7","article-title":"Physicochemical characterization and pharmacokinetics of agomelatine-loaded PLGA microspheres for intramuscular injection","volume":"36","author":"Zhang","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2022.112537_bib9","article-title":"An updated classification of antidepressants: a proposal to simplify treatment","volume":"20","author":"Sebastian","year":"2020","journal-title":"Per. Med. Psychiatry 19"},{"key":"10.1016\/j.colsurfb.2022.112537_bib10","first-page":"8893","volume":"15","author":"Tawfik","year":"2020","journal-title":"Low. -Freq. Versus High. -Freq. Ultrasound-Mediat. transdermal Deliv. agomelatine-loaded invasomes: Dev., Optim. -vivo Pharmacokinet. Assess., Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112537_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.colsurfb.2019.05.016","article-title":"Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: characterization, brain pharmacokinetic study and behavioral study on wistar rats","volume":"181","author":"Ahmed","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2022.112537_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40005-019-00436-0","article-title":"In situ gel of lamotrigine for augmented brain delivery: development characterization and pharmacokinetic evaluation","volume":"50","author":"Parashar","year":"2020","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.colsurfb.2022.112537_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40005-021-00521-3","article-title":"Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson\u2019s disease","volume":"51","author":"Duwa","year":"2021","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.colsurfb.2022.112537_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/pharmaceutics14020359","article-title":"Poly(Lactic Acid)-based microparticles for drug delivery applications: an overview of recent advances","volume":"14","author":"Vlachopoulos","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2022.112537_bib15","first-page":"17","article-title":"A recent update: solid lipid nanoparticles for effective drug delivery","volume":"12","author":"Pandey","year":"2022","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.colsurfb.2022.112537_bib16","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2147\/DDDT.S102500","article-title":"Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics","volume":"11","author":"Fatouh","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2022.112537_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/10717544.2017.1357148","article-title":"Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation","volume":"24","author":"Fatouh","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2022.112537_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4155\/tde-2019-0060","article-title":"Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery","volume":"10","author":"Jani","year":"2019","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.colsurfb.2022.112537_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/IJN.S124703","article-title":"Oral bioavailability enhancement of agomelatine by loading into nanostructured lipid carriers: Peyer\u2019s patch targeting approach","volume":"13","author":"Prajapati","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112537_bib20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jphp.12727","article-title":"High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration","volume":"69","author":"Zeb","year":"2017","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120109","article-title":"Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis","volume":"593","author":"Khan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112537_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2019.02.002","article-title":"Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model","volume":"560","author":"Rizvi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jddst.2019.02.026","article-title":"Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product","volume":"51","author":"Din","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2022.112537_bib26","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.apsb.2020.05.010","article-title":"CORM-2-entrapped ultradeformable liposomes ameliorate acute skin inflammation in an ear edema model via effective CO delivery","volume":"10","author":"Lee","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2022.112537_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111209","article-title":"Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model","volume":"194","author":"Rana","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2022.112537_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120670","article-title":"Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model","volume":"603","author":"Rubab","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fpsyt.2019.00125","article-title":"Leptin prevents lipopolysaccharide-induced depressive-like behaviors in mice: involvement of dopamine receptors","volume":"10","author":"Cordeiro","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.colsurfb.2022.112537_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuro.2019.02.002","article-title":"Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver injury","volume":"72","author":"Khan","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.colsurfb.2022.112537_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12667","article-title":"Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation","volume":"69","author":"Ali","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.colsurfb.2022.112537_bib32","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fnins.2018.00888","article-title":"Identification of proteins differentially expressed in the striatum by melatonin in a middle cerebral artery occlusion rat model-a proteomic and in silico approach","volume":"12","author":"Shah","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.colsurfb.2022.112537_bib33","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/DDDT.S207310","article-title":"Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach","volume":"13","author":"Al Kury","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2022.112537_bib34","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fphar.2018.01383","article-title":"Neuroprotective effect of quercetin against the detrimental effects of LPS in the adult mouse brain","volume":"9","author":"Khan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2022.112537_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119033","article-title":"Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity","volume":"577","author":"Khan","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112537_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/02652048.2017.1337247","article-title":"Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration","volume":"34","author":"Qureshi","year":"2017","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2022.112537_bib38","first-page":"139","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?, Eur","volume":"47","author":"Das","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2022.112537_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.11.040","article-title":"Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"310","author":"Gao","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib40","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2), Trop","volume":"12","author":"Honary","year":"2013","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.colsurfb.2022.112537_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2011.02.012","article-title":"Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release","volume":"79","author":"Souza","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2011.07.040","article-title":"Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application","volume":"419","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2022.112537_bib43","doi-asserted-by":"crossref","first-page":"16668","DOI":"10.1039\/C7RA00552K","article-title":"Nanostructured lipid carrier (NLC)-based novel hydrogels as potential carriers for nepafenac applied after cataract surgery for the treatment of inflammation: design, characterization and in vitro cellular inhibition and uptake studies","volume":"7","author":"Yu","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.colsurfb.2022.112537_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13197-017-2937-5","article-title":"Production and characterization of nanostructured lipid carriers and solid lipid nanoparticles containing lycopene for food fortification","volume":"55","author":"Zardini","year":"2018","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.colsurfb.2022.112537_bib45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10973-015-4890-8","article-title":"Effect of Ouratea sp. butter in the crystallinity of solid lipids used in nanostructured lipid carriers (NLCs)","volume":"123","author":"Galv\u00e3o","year":"2016","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.colsurfb.2022.112537_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.34172\/apb.2021.011","article-title":"Preparation and safety evaluation of topical simvastatin loaded NLCs for vitiligo","volume":"11","author":"Ashtiani","year":"2021","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.colsurfb.2022.112537_bib47","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.2147\/IJN.S91556","article-title":"Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers","volume":"10","author":"Helw","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2022.112537_bib48","first-page":"1159","volume":"18","author":"Abdelbary","year":"2013","journal-title":"Vitr. Charact. Growth Inhib. Eff. Nanostruct. Lipid Carr. Control. Deliv. Methotrexate, Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2022.112537_bib49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbr.2017.05.064","article-title":"Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depression","volume":"364","author":"Zhao","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.colsurfb.2022.112537_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.colsurfb.2022.112537_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3233\/JAD-190083","article-title":"Neuroprotective potential of curcumin-loaded nanostructured lipid carrier in an animal model of Alzheimer\u2019s disease: behavioral and biochemical evidence","volume":"69","author":"Sadegh Malvajerd","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.colsurfb.2022.112537_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112537_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2022.112537_bib54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid lipid nanoparticles for targeted brain drug delivery","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652200220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652200220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:07:33Z","timestamp":1760526453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777652200220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":54,"alternative-id":["S092777652200220X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112537","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112537"}}